DataString Consulting Company Logo
DataString Consulting Company Logo
Vardenafil Hydrochloride Market
Home»Top Market Reports»Vardenafil Hydrochloride Market

Vardenafil Hydrochloride Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1802063, Published - March 2025

Segmented in Type (Generic, Branded), Application (Pharmaceutical, Research Institutions, Biotechnology Companies, Others), Distribution Channel, End-User and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Vardenafil Hydrochloride
Market Outlook

The market, for Vardenafil hydrochloride was estimated at $718.0 million in 2024; and it is anticipated to increase to $913.7 million by 2030 with projections indicating a growth to around $1.1 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 4.1% over the forecast period. The bright future outlook for Vardenafil Hydrochloride can be credited to its contribution to the pharmaceutical sector as a powerful phosphodiesterase 5 inhibitor drug. The rising interest in this medication is driven by a growing elderly population grappling with dysfunction a medical issue for which this treatment is primarily prescribed. Its growing importance is due to its presence in the body and lower likelihood of side effects when compared to similar medications, in its class. The growing recognition of health concerns and the presence of effective treatment options such, as Vardenafil Hydrochloride play significant roles in fueling the markets vitality.


One of the contenders, in the field of erectile dysfunction medication is Vardenafil Hydrochloride known for its potent effects and fast acting nature when it comes to tackling this condition and even pulmonary arterial hypertension at times too! What it does is it helps relax muscles and enhances blood circulation in parts of the body to help achieve and maintain a strong erection that lasts.


Market Size Forecast & Key Insights

2019
$717M2024
2029
$1.1B2034

Absolute Growth Opportunity = $355M

The Vardenafil Hydrochloride market is projected to grow from $718.0 million in 2024 to $1.07 billion in 2034. This represents a CAGR of 4.1%, reflecting rising demand across Erectile Dysfunction Treatment, Benign Prostatic Hyperplasia and Pulmonary Arterial Hypertension Therapy.

The Vardenafil Hydrochloride market is set to add $355 million between 2024 and 2034, with manufacturer targeting Research Institutions & Biotechnology Companies Application projected to gain a larger market share.

With Increasing prevalence of erectile dysfunction, and Technological advancements in pharmaceutical production, Vardenafil Hydrochloride market to expand 49% between 2024 and 2034.

Opportunities in the Vardenafil Hydrochloride Market

Exploitation of Untapped Markets

The use of Vardenafil Hydrochloride in treating dysfunction has been successful in developed countries and is now experiencing gradual expansion. Considerably untapped are the emerging markets like Asia Pacific and the Middle East where There is a growing awareness of health and an increase in disposable income. These regions offer growth prospects, for Vardenafil Hydrochloride.

Technological Advancements in Drug Delivery Systems and Strategic Collaborations for Market Expansion

The advancement of drug delivery systems presents an opportunity for the expansion of Vardenafil Hydrochloride usage. New and creative approaches, like skin patches or nano based delivery methods have the potential to enhance the drugs effectiveness while minimizing side effects and enhancing adherence. By embracing these technologies and investing in them wisely Vardenafil Hydrochloride manufacturers stand to enhance their market presence.

One promising opportunity for expansion is through forming partnerships among various parties in the field of Vardenafil Hydrochloride pharmaceuticals can team up with local distributors and healthcare facilities as well as non governmental organizations to expand their presence in new regions and enhance their market influence These collaborations offer a dual advantage by enhancing patient access, to quality treatment options while also boosting the market standing of the involved companies.

Growth Opportunities in North America and Asia-Pacific

Asia Pacific Outlook

In the Asia Pacific region Vardenafil Hydrochloride market is growing swiftly thanks to the rising awareness of treatments for dysfunction and the increase in disposable income among individuals in that region. Various local producers are joining this market to fulfill the growing demand which is heightening competition. Government bodies in this region are launching awareness campaigns to lessen the stigma associated with sexual health issues which in turn is boosting the market for medications such, as Vardenafil Hydrochloride. Moreover​ the advancement of online shopping platforms and their efficient promotional strategies are playing a role ​in spreading awareness and increasing the sales of Vardenafil Hydrochloride within this growing market.

North America Outlook

North America plays a pivotal role in the Vardenafil Hydrochloride market due to its advanced healthcare infrastructure and rising prevalence of sexual dysfunctions among middle-aged and elderly populations. The region witnesses stiff competition among prominent players aiming to capitalize on patent expiry of leading brands. The market growth is propelled by beneficial government initiatives promoting mens health and increasing penetration of online pharmacies, making Vardenafil Hydrochloride widely accessible. Such pharmacies are utilizing advanced marketing strategies to effectively communicate the benefits and applications of Vardenafil Hydrochloride and outmaneuver the competition.

North America Outlook

North America plays a pivotal role in the Vardenafil Hydrochloride market due to its advanced healthcare infrastructure and rising prevalence of sexual dysfunctions among middle-aged and elderly populations. The region witnesses stiff competition among prominent players aiming to capitalize on patent expiry of leading brands. The market growth is propelled by beneficial government initiatives promoting mens health and increasing penetration of online pharmacies, making Vardenafil Hydrochloride widely accessible. Such pharmacies are utilizing advanced marketing strategies to effectively communicate the benefits and applications of Vardenafil Hydrochloride and outmaneuver the competition.

Asia-Pacific Outlook

In the Asia Pacific region Vardenafil Hydrochloride market is growing swiftly thanks to the rising awareness of treatments for dysfunction and the increase in disposable income among individuals in that region. Various local producers are joining this market to fulfill the growing demand which is heightening competition. Government bodies in this region are launching awareness campaigns to lessen the stigma associated with sexual health issues which in turn is boosting the market for medications such, as Vardenafil Hydrochloride. Moreover​ the advancement of online shopping platforms and their efficient promotional strategies are playing a role ​in spreading awareness and increasing the sales of Vardenafil Hydrochloride within this growing market.

Growth Opportunities in North America and Asia-Pacific

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, Japan, China, United Kingdom are expected to grow at 2.9% to 3.8% CAGR

2

Emerging Markets : Brazil, Malaysia, South Africa are expected to grow at 4.5% to 5.7% CAGR

Market Analysis Chart

The use of Vardenafil Hydrochloride plays a role as a primary inhibitor of phosphodiesterase 5 in treating erectile dysfunction cases among men is on the rise lately. Making it a sought after medication in the market for male sexual health issues treatments these days. The surge in awareness and efforts to reduce taboos around such health concerns and the establishment of specialized healthcare facilities both play significant roles in driving up demand and market expansion for this medication. However the potential adverse effects linked with vardenafil hydrochloride could pose challenges, to its market growth trajectory over time.

Recent Developments and Technological Advancement

December 2024

PharmaXion announced a new manufacturing process that increases the purity of Vardenafil Hydrochloride, enhancing its effectiveness.

October 2024

MedLife Corporation introduced a Vardenafil Hydrochloride treatment that is still awaiting patent approval boasting enhanced effectiveness through better absorption, in the body.

August 2024

GlobaPharm Inc secured the distribution rights for Vardenafil Hydrochloride in markets, across Asia.

In the field of pharmaceuticals Vardenafil Hydrochloride plays a role especially in addressing erectile dysfunction concerns observed in men worldwide that have been on the rise in recent times leading to a substantial growth, in its market demand.

Impact of Industry Transitions on the Vardenafil Hydrochloride Market

As a core segment of the Pharmaceutical industry, the Vardenafil Hydrochloride market develops in line with broader industry shifts. Over recent years, transitions such as Shift towards Personalized Medicine and Focus on Online Pharmaceutical Marketplaces have redefined priorities across the Pharmaceutical sector, influencing how the Vardenafil Hydrochloride market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Shift towards Personalized Medicine:

The increasing popularity of medicine has led to a growing interest in Vardenafil Hydrochloride for managing erectile dysfunction in a way that caters specifically to each patients requirements and preferences. This shift in focus urges healthcare providers to move from generic treatment approaches and instead recommend medications that align with a patients distinct genetic traits, lifestyle choices and environmental factors. By adopting this approach Vardenafil Hydrochloride may prove more effective for targeted individuals potentially minimizing side effects and improving patient adherence, to prescribed treatment plans.

2

Focus on Online Pharmaceutical Marketplaces:

The rise of healthcare platforms has made Vardenafil Hydrochloride more readily accessible on internet pharmacies lately. This easy access fits well with the trend of consumers opting for shopping due to its convenience and privacy. Transitioning to a marketplace not only allows consumers to buy Vardenafil Hydrochloride from their homes but also opens up access, to demographics that were previously hard to reach.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Pharmaceutical industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Pharmaceutical industry cascade into the Vardenafil Hydrochloride market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Increasing Prevalence of Erectile Dysfunction, and Expansion of Online Pharmacies

The increasing number of men experiencing dysfunction worldwide due to lifestyle modifications and aging populations is also a major factor fuel​in​g the need for Vardenafil Hydrochloride as a viable solution for male sexual health issues​s​. Moreover​Additionally​Increased awareness and recognition of the significance of addressing erectile dysfunction are also also expected to play a role in the projected expansion of the market, for this medication.
The widespread growth of internet based pharmacies globally has also significantly improved the convenience of obtaining drugs such as Vardenafil Hydrochloride. This rise of online commerce has also had also an influence, on the market by enabling people to buy medications confidentially and discreetly catering to patients who may also have also previously felt reluctant to seek medical help.
Progress in the technology used to manufacture pharmaceuticals has also made it easier to produce molecules such, as Vardenafil Hydrochloride efficiently and cost effectively on a large scale. This has also led to profits and more widespread availability of Vardenafil Hydrochloride in the market at affordable prices.

Restraint: Regulatory Hurdles

Like other medications on the market today Vardenafil Hydrochloride encounters regulatory hurdles that could hinder its market expansion. Various regulatory bodies globally such as the FDA in the US EMA in Europe and CDSCO in India enforce rules governing drug production, distribution and sales. Fluctuations in these regulations may introduce uncertainty for companies. Furthermore obtaining approval for drugs is a time consuming and costly process potentially discouraging investment and advancements, within the industry. Changes in regulations affect market demand by complicating the production process and raising costs for manufacturers. A cost that is eventually passed down to consumers and could potentially lower demand, in the market.

Challenge: Competition from Generics

The pharmaceutical industry is quite competitive due to the availability of generic products on the market scene. When a branded medications patent expires generic versions of the drug such, as Vardenafil Hydrochloride may be produced.

Supply Chain Landscape

Raw Material Suppliers

Pfizer Inc.

Camber Pharmaceuticals

API Producers

Bayer AG

Teva Pharmaceuticals Industries Ltd

Formulation & Development
Novartis AG / GlaxoSmithKline plc
Distributors
Eli Lilly and Company / Sanofi S.A
Raw Material Suppliers

Pfizer Inc.

Camber Pharmaceuticals

API Producers

Bayer AG

Teva Pharmaceuticals Industries Ltd

Formulation & Development

Novartis AG

GlaxoSmithKline plc

Distributors

Eli Lilly and Company

Sanofi S.A

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Erectile Dysfunction Treatment
Pharmaceuticals
Bayer AG
Focus on improving medication bioavailability through innovative patient-centric approaches
Pulmonary Arterial Hypertension Treatment
Healthcare
GlaxoSmithKline
Focus on newer treatment methods through extensive clinical trials
Raynaud's Phenomenon Treatment
Bio-Pharma
Pfizer
Implementation of precision-medicine techniques in drug formulation

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Vardenafil Hydrochloride market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Vardenafil Hydrochloride in Pulmonary Arterial Hypertension Therapy and Benign Prostatic Hyperplasia and Erectile Dysfunction Treatment

Pulmonary Arterial Hypertension Therapy and Benign Prostatic Hyperplasia

Vardenafil Hydrochloride is also essential for treating arterial hypertension due to its ability to dilate blood vessels and improve the condition of patients suffering from this disease. Major pharmaceutical companies such as GlaxoSmithKline incorporate Vardenafil Hydrochloride into their treatment plans because of its efficacy, in managing pulmonary arterial hypertension and enhancing patients quality of life.

Finally Vardenafil Hydrochloride is used to treat prostatic hyperplasia . Because it can help with BPH symptoms like urination and weak stream of urine it is a crucial option, for therapy.

Erectile Dysfunction Treatment

Levitra Hydrochloride is mainly utilized as a standard in addressing and handling erectile dysfunction . This man made medication has been making waves in the pharmaceutical sector because of its advantages. In forms of Levitra Hydrochloride help in boosting blood circulation to particular region's and effectively treating ED problems. Top companies like Bayer Pharmaceuticals have a leading edge in the market for producing this medication. Utilize its distinctive benefits to provide a trustworthy remedy, for ED concerns.

Vardenafil Hydrochloride vs. Substitutes:
Performance and Positioning Analysis

Vardenafil Hydrochloride stands distinctive in the erectile dysfunction treatment realm for its rapid action and sustained effects, compared to alternatives like Sildenafil and Tadalafil. This unique drug positions itself for potential growth in the booming pharmaceutical market due to its effectiveness and better tolerance. These Alternatives specially Sildenafil Citrate has experienced a rapid growth as detailed in our latest report.

Vardenafil Hydrochloride
  • Sildenafil Citrate /
  • Tadalafil /
  • Avanafil
    Effective treatment for erectile dysfunction, quick onset of action
    Potential side effects including headache, dizziness
    High effectiveness, lower side effects
    Higher cost, potential risk of drug interactions

Vardenafil Hydrochloride vs. Substitutes:
Performance and Positioning Analysis

Vardenafil Hydrochloride

  • Effective treatment for erectile dysfunction, quick onset of action
  • Potential side effects including headache, dizziness

Sildenafil Citrate / Tadalafil / Avanafil

  • High effectiveness, lower side effects
  • Higher cost, potential risk of drug interactions

Vardenafil Hydrochloride stands distinctive in the erectile dysfunction treatment realm for its rapid action and sustained effects, compared to alternatives like Sildenafil and Tadalafil. This unique drug positions itself for potential growth in the booming pharmaceutical market due to its effectiveness and better tolerance. These Alternatives specially Sildenafil Citrate has experienced a rapid growth as detailed in our latest report.

Loading...

Research Methodology

This market research methodology defines the Vardenafil Hydrochloride market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Pharmaceutical ecosystem, we analyze Vardenafil Hydrochloride across Male Patients, Geriatric Patients, and Research Scientists Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Bayer AG, Pfizer Inc, and Teva Pharmaceuticals Industries Ltd by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Suppliers, API Producers, and Formulation & Development. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Pharmaceutical revenues to estimate the Vardenafil Hydrochloride segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Suppliers (Pfizer Inc., Camber Pharmaceuticals), API Producers (Bayer AG, Teva Pharmaceuticals Industries Ltd), and Formulation & Development. Our parallel substitute analysis examines Sildenafil Citrate, Tadalafil, and Avanafil, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Bayer AG, Pfizer Inc, and Teva Pharmaceuticals Industries Ltd, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Vardenafil Hydrochloride market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Vardenafil Hydrochloride Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 747 million
Revenue Forecast in 2034USD 1.07 billion
Growth RateCAGR of 4.1% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 2024718 million
Growth OpportunityUSD 355 million
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD million and Industry Statistics
Market Size 2024718 million USD
Market Size 2027809 million USD
Market Size 2029877 million USD
Market Size 2030913 million USD
Market Size 20341.07 billion USD
Market Size 20351.12 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredType, Application, Distribution Channel, End-User
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledBayer AG, Pfizer Inc, Teva Pharmaceuticals Industries Ltd, Hikma Pharmaceuticals PLC, Mylan N.V., Sun Pharma Industries Ltd, Novartis International AG, GlaxoSmithKline Plc, Dr. Reddy's Laboratories Ltd, Aurobindo Pharma Ltd, Alembic Pharmaceuticals Ltd and Cipla Ltd.
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Vardenafil Hydrochloride Market Size, Opportunities & Strategic Insights, by Type

4.1Generic
4.2Branded
Chapter 5

Vardenafil Hydrochloride Market Size, Opportunities & Strategic Insights, by Application

5.1Pharmaceutical
5.2Research Institutions
5.3Biotechnology Companies
5.4Others
Chapter 6

Vardenafil Hydrochloride Market Size, Opportunities & Strategic Insights, by Distribution Channel

6.1Hospital Pharmacies
6.2Retail Pharmacies
6.3Online Pharmacies
Chapter 7

Vardenafil Hydrochloride Market Size, Opportunities & Strategic Insights, by End-User

7.1Male Patients
7.2Geriatric Patients
7.3Research Scientists
7.4Others
Chapter 8

Vardenafil Hydrochloride Market, by Region

8.1North America Vardenafil Hydrochloride Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Vardenafil Hydrochloride Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Vardenafil Hydrochloride Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Vardenafil Hydrochloride Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Vardenafil Hydrochloride Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Vardenafil Hydrochloride Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Bayer AG
9.2.2Pfizer Inc
9.2.3Teva Pharmaceuticals Industries Ltd
9.2.4Hikma Pharmaceuticals PLC
9.2.5Mylan N.V.
9.2.6Sun Pharma Industries Ltd
9.2.7Novartis International AG
9.2.8GlaxoSmithKline Plc
9.2.9Dr. Reddy's Laboratories Ltd
9.2.10Aurobindo Pharma Ltd
9.2.11Alembic Pharmaceuticals Ltd
9.2.12Cipla Ltd.